The effects of gammahydroxybutyrate on hypermetabolism and wound healing in a rat model of large thermal injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 63, Issue 5, 2007, Pages 1099-1107

  Murphy, Kevin D ^a   Rose, Mary W ^b   Chinkes, David L ^c,d   Meyer III, Walter J ^c,e   Herndon, David N ^c,d   Hawkins, Hal K ^c,d   Sanford, Arthur P ^c,d  

^a ULSTER HOSPITAL   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Anabolic; Burns; Gammahydroxybutyrate; Growth hormone; Hypermetabolism; Sleep; Wound healing

Indexed keywords

4 HYDROXYBUTYRIC ACID; GROWTH HORMONE; IMMUNOGLOBULIN G1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY SURFACE; BODY WEIGHT; BONE MINERAL; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EPITHELIZATION; GROWTH HORMONE BLOOD LEVEL; HYPERMETABOLISM; LEAN BODY WEIGHT; MALE; METABOLIC PARAMETERS; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL INJURY; TISSUE SECTION; WOUND HEALING;

ANESTHETICS, INTRAVENOUS; ANIMALS; BODY COMPOSITION; BONE DENSITY; BURNS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MALE; METABOLIC DISEASES; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; SODIUM OXYBATE; TREATMENT OUTCOME; WOUND HEALING;

EID: 36048945027     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318157d9d0     Document Type: Article

References (58)

1. Herruzocabrera R, Fernandezarjona M, Garciatorres V, et al. Mortality evolution study of burn patients in a critical care burn unit between 1971 and 1991. Burns. 1995;21:106-109.
2. Wolf SE, Rose JK, Desai MH, et al. Mortality determinants in massive pediatric burns - an analysis of 103 children with 80% TBSA burns (≥70% full-thickness). Ann Surg. 1997;225:554-565.
3. Drost AC, Burleson DG, Cioffi WG, et al. Plasma cytokines after thermal-injury and their relationship to infection. Ann Surg. 1993;218:74-78.
4. Oriordain MG, Collins KH, Pilz M, et al. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch Surg. 1992;127:152-157.
5. Jackson D, Topley E, Cason JS, et al. Primary excision and grafting of large burns. Ann Surg. 1960;152:167-189.
6. Drost AC, Burleson DG, Cioffi WG, et al. Plasma cytokines following thermal-injury and their relationship with patient mortality, burn size, and time postburn. J Trauma. 1993;35:335-339.
7. Debandt JP, Cholletmartin S, Hernvann A, et al. Cytokine response to burn injury - relationship with protein-metabolism. J Trauma. 1994;36:624-628.
8. Wang P, Li JS, Li WQ. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity. World J Gastroenterol. 2002;8:531-536.
9. Kataranovski M, Magic Z, Pejnovic N. Early inflammatory cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res. 1999;48:473-482.
10. Wilmore DW, Aulick LH. Metabolic changes in burned patients. Surg Clin North Am. 1978;58:1173-1187.
11. Sanford A, Herndon DN. Modulation of the Hypermetabolic Response to Burn Injury and Trauma. Berlin: Springer Verlag; 1999.
12. Klein GL, Herndon DN, Goodman WG, et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 1995;17:455-460.
13. Takahara J, Yonoki S, Hosogi H, et al. Concomitant increases in serum growth hormone and hypothalamic somatostatin in rats after injection of gamma-aminobutyric acid, aminooxyacetic acid, or gamma-hydroxybutyric acid. Endocrinology. 1980;106:343-347.
14. Ghaemi SN, Irizarry MC. Parasomnias as neuropsychiatric complications of electrical injury. Psychosomatics. 1995;36:416.
15. Jefferies MK, Vance ML. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil. 1992;13:391-395.
16. Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg. 2000;232:455-465.
17. Klein GL, Wolf SE, Langman CB, et al. Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab. 1998;83:21-24.
18. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg. 2001;233:556-564.
19. Ramirez RJ, Wolf SE, Barrow RE, et al. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg. 1998;228:439-446.
20. Low JFA, Barrow RE, Mittendorfer B, et al. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns. 2001;27:447-452.
21. Takagi K, Suzuki F, Barrow RE, et al. Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg. 1998;228:106-111.
22. Jeschke MG, Barrow RE, Herndon DN. Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children. Ann Surg. 2000;231:246-252.
23. Spies M, Wolf SE, Barrow RE, et al. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med. 2002;30:83-88.
24. Thomas S, Wolf SE, Murphy KD, et al. The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children. J Trauma. 2004;56:37-43.
25. Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Invest. 1968;47:2079-2090.
26. Klein GL, Wolf SE, Goodman WG, et al. The management of acute bone loss in severe catabolism due to burn injury. Horm Res. 1997;48:83-87.
27. Herndon DN, Barrow RE, Kunkel SL, et al. Effects of recombinant growth hormone in donor-site healing in severely burned children. Ann Surg. 1990;212:424-431.
28. Jensche MG, Chrysopoulo MT, Herndon DN, et al. Increased expression of insulin-like growth factor-1 in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res. 1999;85:171-177.
29. Herndon DN, Hawkins HK, Nguyen TT, et al. Characterization of growth-hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg. 1995;221:649-659.
30. Scharf MB, Lai AA, Branigan B, et al. Pharmokinetics of Gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep. 1998;21:507-514.
31. Winickoff JP, Houck CS, Rothman EL, et al. Verve and jolt: deadly new Internet drugs. Pediatrics. 2000;106:829-831.
32. Carai MA, Colombo G, Brunetti G, et al. Role of GABAB receptors in the sedative/hypnotic effects of -hydroxybutyric acid. Eur J Pharmacol. 2001;428:315-321.
33. Chaminov M, Bahar M, Cohen ML, et al. Spinal anaesthesia with gamma hydroxybutyrate. A study in a rat model. Eur J Anaesthesiol. 2003;16:330-338.
34. Scharf MB, Hauck M, Stover R, et al. Effects of gamma hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. J Rheumatol. 1998;25:1986-1990.
35. Lammers GJ, Arends J, Declerck AC, et al. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep. 1993;16:216-220.
36. Scharf MB, Brown D, Woods M, et al. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry. 1985;46:222-225.
37. Van Cauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest. 1997;100:745-753.
38. Andriamampandry C, Taleb O, Viry S, et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate. FASEB J. 2003;17:1691-1693.
39. Van Cauter E, Plat L. Physiology of growth hormone secretion during sleep. J Pediatr. 1996;128:S32-S37.
40. Brandenberger G, Gronfier C, Chapotot F, et al. Effect of sleep deprivation on overall 24 h growth-hormone secretion. Lancet. 2000;356:1408.
41. Davidson JR, Moldofsky H, Lue FA. Growth hormone and cortisol secretion in relation to sleep and wakefulness. J Psychiatry Neurosci. 2002;16:96-102.
42. Czeisler CA, Klerman EB. Circadian and sleep-dependent regulation of hormone release in humans. Recent Prog Horm Res. 1999;54:97-132.
43. Weyerbrock A, Timmer J, Hohagen F, et al. Effects of light and chronotherapy on human circadian rhythms in delayed sleep phase syndrome: cytokines, cortisol, growth hormone, and the sleep-wake cycle. Biol Psychiatry. 1996;40:794-797.
44. Holzheimer RG, Curley P, Saporoschetz IB, et al. Circadian Rhythm of cytokine secretion following thermal injury in mice: implications for burn and trauma research. Shock. 2002;17:527-529.
45. Noordenbos J, Hansbrough JF, Gutmacher H, et al. Enteral nutritional support and wound excision and closure do not prevent postburn hypermetabolism as measured by continuous metabolic monitoring. J Trauma. 2000;49:667-671.
46. Sassin JF, Parker DC, Mace JW, et al. Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science. 1969;165:513-515.
47. Van Cauter E, Kerkofs M, Caufriez A, et al. A quantitative estimation of GH secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endochrinol Metab. 1992;74:1441-1450.
48. Van Cauter E, Latta F, Nedeltcheva A, et al. Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res. 2004;14(Suppl):S10- S17.
49. Jarrett DB, Greenhouse JB, Miewald JM, et al. A reexamination of the relationship between growth-hormone secretion and slow-wave sleep using delta-wave analysis. Biol Psychiatry. 1990;27:497-509.
50. Rose M, Sanford A, Thomas C. Factors altering the sleep of burned children. Sleep. 2001;24:45-51.
51. Clinical Trials.gov identifier NCT00244465. Post-Marketing Non-Interventional Pharmacoepidemiology Study to evaluate long-term safety, tolerability and compliance in administration of Xyrem (sodium oxybate) in regular clinical practice. Clinical Trials.gov identifier NCT00244465; 2006.
52. Lorente P, Lacampagne A, Pouzeratte Y, et al. Gamma-aminobutyric acid type B receptors are expressed and functional in mammalian cardiomyocytes. Proc Natl Acad Sci U S A. 2000;97:8664-8669.
53. Hart DW, Wolf SE, Chinkes DL, et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma. 2003;54:755-761.
54. Jeschke MG, Wolf SE, DebRoy MA, et al. The combination of growth hormone with hepatocyte growth factor alters the acute phase response. Shock. 1999;12:181-187.
55. Jeschke MG, Herndon DN, Wolf SE, et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res. 1999;83:122-129.
56. Rudman A, Feller AG, Nagraj HS. Effect of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1-6.
57. Pearlman CA, Greenberg R. Medical-psychological implications of recent sleep research. Psychiatry Med. 1970;1:261-276.
58. Schmidt-Mutter C, Gobaille S, Muller C, et al. Prodynorphin and proenkephalin mRNAs are increased in rat brain after acute and chronic administration of gamma-hydroxybutyrate. Neurosci Lett. 1999;262:65-68.